Skip to main

Navidea Biopharma

NAVB is nowNAVBQ
NAVB logo
This stock has changed its ticker name. This happens for a variety of reason, including a corporate merger or simply a change in company name.
Learn More
Go to the new stock page

Frequently Asked Questions (FAQ)

As of Oct 07, 2025, the market cap for NAVB stock is $10K

The 52-week high for NAVB stock is $0.05. The current NAVB stock price $undefined is 100.00% below its 52-week high

The 52-week low for NAVB stock is $0.00. The current NAVB stock price $undefined has increased 100.00% from its 52-week low

No, the NAVB stock does not pay dividends to its shareholders

How to buy NAVB stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in NAVB stock

    Navigate to the Explore page. Then, type NAVB into the search bar. When you see NAVB stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased NAVB stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Navidea Biopharma Stock Earnings

The value each NAVB share was expected to gain vs. the value that each NAVB share actually gained.

Navidea Biopharma (NAVB) reported Q3 2021 earnings per share (EPS) of -$0.08, beating estimates of -$0.11 by 27.27%. In the same quarter last year, Navidea Biopharma's earnings per share (EPS) was -$0.13. Navidea Biopharma is expected to release next earnings on 11/14/2023, with an earnings per share (EPS) estimate of $0.

Buy Navidea Biopharma (NAVB) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.